Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071437006> ?p ?o ?g. }
- W2071437006 endingPage "299" @default.
- W2071437006 startingPage "291" @default.
- W2071437006 abstract "We describe a strategy for comprehending signaling pathways that are active in lung cancer cells and that are targeted by dasatinib using chemical proteomics to identify direct interacting proteins combined with immunoaffinity purification of tyrosine-phosphorylated peptides corresponding to activated tyrosine kinases. We identified nearly 40 different kinase targets of dasatinib. These include SRC-family kinase (SFK) members (LYN, SRC, FYN, LCK and YES), nonreceptor tyrosine kinases (FRK, BRK and ACK) and receptor tyrosine kinases (Ephrin receptors, DDR1 and EGFR). Using quantitative phosphoproteomics, we identified peptides corresponding to autophosphorylation sites of these tyrosine kinases that are inhibited in a concentration-dependent manner by dasatinib. Using drug-resistant gatekeeper mutants, we show that SFKs (particularly SRC and FYN), as well as EGFR, are relevant targets for dasatinib action. The combined mass spectrometry-based approach described here provides a system-level view of dasatinib action in cancer cells and suggests both functional targets and a rationale for combinatorial therapeutic strategies." @default.
- W2071437006 created "2016-06-24" @default.
- W2071437006 creator A5002876951 @default.
- W2071437006 creator A5007854629 @default.
- W2071437006 creator A5010264712 @default.
- W2071437006 creator A5012452779 @default.
- W2071437006 creator A5013240234 @default.
- W2071437006 creator A5018246775 @default.
- W2071437006 creator A5029758467 @default.
- W2071437006 creator A5036045996 @default.
- W2071437006 creator A5040664475 @default.
- W2071437006 creator A5064494204 @default.
- W2071437006 creator A5069216326 @default.
- W2071437006 creator A5076672524 @default.
- W2071437006 creator A5088881177 @default.
- W2071437006 date "2010-02-28" @default.
- W2071437006 modified "2023-10-16" @default.
- W2071437006 title "A chemical and phosphoproteomic characterization of dasatinib action in lung cancer" @default.
- W2071437006 cites W1639582946 @default.
- W2071437006 cites W1965095341 @default.
- W2071437006 cites W1968327387 @default.
- W2071437006 cites W1970213932 @default.
- W2071437006 cites W1971239528 @default.
- W2071437006 cites W1972424044 @default.
- W2071437006 cites W1983225862 @default.
- W2071437006 cites W1983392133 @default.
- W2071437006 cites W1986139301 @default.
- W2071437006 cites W1989410548 @default.
- W2071437006 cites W1990353912 @default.
- W2071437006 cites W1991795177 @default.
- W2071437006 cites W2002790722 @default.
- W2071437006 cites W2002937040 @default.
- W2071437006 cites W2008345619 @default.
- W2071437006 cites W2014582878 @default.
- W2071437006 cites W2025535065 @default.
- W2071437006 cites W2026279585 @default.
- W2071437006 cites W2026542427 @default.
- W2071437006 cites W2028666409 @default.
- W2071437006 cites W2032775411 @default.
- W2071437006 cites W2036988959 @default.
- W2071437006 cites W2043696829 @default.
- W2071437006 cites W2051183427 @default.
- W2071437006 cites W2060882055 @default.
- W2071437006 cites W2062709744 @default.
- W2071437006 cites W2072685915 @default.
- W2071437006 cites W2075215651 @default.
- W2071437006 cites W2075954169 @default.
- W2071437006 cites W2075985845 @default.
- W2071437006 cites W2076718022 @default.
- W2071437006 cites W2087472895 @default.
- W2071437006 cites W2091322376 @default.
- W2071437006 cites W2092608482 @default.
- W2071437006 cites W2093616162 @default.
- W2071437006 cites W2097312459 @default.
- W2071437006 cites W2099580743 @default.
- W2071437006 cites W2100772783 @default.
- W2071437006 cites W2108257186 @default.
- W2071437006 cites W2132448632 @default.
- W2071437006 cites W2134672568 @default.
- W2071437006 cites W2138067522 @default.
- W2071437006 cites W2139236349 @default.
- W2071437006 cites W2147887967 @default.
- W2071437006 cites W2153516980 @default.
- W2071437006 cites W2161821474 @default.
- W2071437006 cites W2165947407 @default.
- W2071437006 cites W2166457287 @default.
- W2071437006 cites W2167368929 @default.
- W2071437006 cites W2168691181 @default.
- W2071437006 doi "https://doi.org/10.1038/nchembio.332" @default.
- W2071437006 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2842457" @default.
- W2071437006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20190765" @default.
- W2071437006 hasPublicationYear "2010" @default.
- W2071437006 type Work @default.
- W2071437006 sameAs 2071437006 @default.
- W2071437006 citedByCount "245" @default.
- W2071437006 countsByYear W20714370062012 @default.
- W2071437006 countsByYear W20714370062013 @default.
- W2071437006 countsByYear W20714370062014 @default.
- W2071437006 countsByYear W20714370062015 @default.
- W2071437006 countsByYear W20714370062016 @default.
- W2071437006 countsByYear W20714370062017 @default.
- W2071437006 countsByYear W20714370062018 @default.
- W2071437006 countsByYear W20714370062019 @default.
- W2071437006 countsByYear W20714370062020 @default.
- W2071437006 countsByYear W20714370062021 @default.
- W2071437006 countsByYear W20714370062022 @default.
- W2071437006 countsByYear W20714370062023 @default.
- W2071437006 crossrefType "journal-article" @default.
- W2071437006 hasAuthorship W2071437006A5002876951 @default.
- W2071437006 hasAuthorship W2071437006A5007854629 @default.
- W2071437006 hasAuthorship W2071437006A5010264712 @default.
- W2071437006 hasAuthorship W2071437006A5012452779 @default.
- W2071437006 hasAuthorship W2071437006A5013240234 @default.
- W2071437006 hasAuthorship W2071437006A5018246775 @default.
- W2071437006 hasAuthorship W2071437006A5029758467 @default.
- W2071437006 hasAuthorship W2071437006A5036045996 @default.
- W2071437006 hasAuthorship W2071437006A5040664475 @default.
- W2071437006 hasAuthorship W2071437006A5064494204 @default.